About the Event
Date:2024 | To Be Announced
Location:Location To Be Announced
Credit:CME: 40.75, ABIM & ABP MOC: 40.75
On Demand:Available May 10, 2023–April 29, 2024
Six meetings took place from April 28–30, 2023 at the Hyatt Regency in Orlando, Florida, including:
- State-of-the-Art Clinical Symposium (SOTA)
- Fellows in Training (FIT) at Education Exchange
- Coding Guidelines Workshop – Updates & Impacts
- ACR/ARP Access in Rheumatology Meeting
- Educators Conference (formerly Program Directors Conference)
- Division Directors Conference
On-demand access will include recordings of each lecture (except the Coding Guidelines Workshop, which is not available on demand) and the 10-minute Q&A which followed most lectures.
Share best practices from your division or training program, get the latest coding and billing updates, share pain points with payors and try to come up with solutions, hear the latest state-of-the-art clinical updates to help you care for patients, and more. Education Exchange has programming to help you get your job done.
Program Schedule & Syllabi
ACR Education Exchange Program Schedule at a Glance
Registered attendees can access the syllabi during the meeting and for 12 months after the meeting. To access syllabi, login and go to My Learning.
ACR/ARP Members: $350
Potential Members: $500
The American College of Rheumatology thanks our corporate supporters and partners for their commitment to advancing rheumatology by supporting ACR and ARP programs and initiatives.
Educational grant support for this activity has been provided by Pfizer and Janssen.
See current supporters, guidelines, and benefits of supporting the ACR.
This activity has been approved for 40.75 AMA PRA Category 1 Credit(s)™.
- ACR/ARP Access in Rheumatology Meeting: 2.50 CME credits/MOC points
- Coding Guidelines Workshop – Updates & Impacts: 6.30 CME credits/MOC points
- Division Directors Conference: 3.00 CME credits/MOC points
- Educators Conference: 9.50 CME credits/MOC points
- Fellows in Training (FIT) at Education Exchange: 7.60 CME credits/MOC points
- State-of-the-Art Clinical Symposium: 12.00 CME credits/MOC points
Global Learning Objectives
Upon completion of this activity, participants should be able to:
- Discuss the most up-to-date evidence-based treatment approaches in the management of rheumatic diseases.
- Identify and describe recent scientific and clinical advances regarding the pathogenesis of rheumatic diseases.
- Apply new research data to improve the quality of care of patients with rheumatic diseases.
- Identify the vital issues involved with running academic divisions in rheumatology.
- Identify CPT coding updates and payment policies affecting rheumatology practices.
The American College of Rheumatology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
See the ACR’s CME Mission Statement. For more information, download the AMA PRA Booklet.
The ACR designates this blended learning activity encompassing live and on demand activity for a maximum of 40.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CME credit must be claimed by March 26, 2024 at 11:59 PM ET.
MOC Recognition Statement
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 40.20 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
By completing this activity, you provide the ACR permission to share completion data with the ACCME and the certifying board.
After submitting a reflective statement with key takeaways from the meeting, MOC points will be applied for ABIM diplomates to the ABIM diplomate number and date of birth provided when you registered. Points are sent nightly to ACCME and then transferred to the ABIM Physician Portal. Please allow at least 48 hours for points to display in the portal.
American Board of Pediatrics (ABP)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn up to 40.75 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABP MOC credit.
After submitting a reflective statement with key takeaways from the meeting, MOC points will be applied for ABP diplomates to the ABP diplomate number and date of birth provided when you registered. Points are sent nightly to ACCME and then transferred to the ABP Physician Portals. Please allow at least 48 hours for points to display in the portal.
MOC points must be claimed by December 31, 2023 at 11:59 PM ET.
ACR Disclosure Statement
It is the policy of the American College of Rheumatology (ACR) to ensure that Continuing Medical Education (CME) activities are independent and free of commercial bias. To ensure educational content is objective, balanced, and guarantee content presented is in the best interest of its learners' and the public, the ACR requires that everyone in a position to control educational content disclose all financial relationships with ineligible companies within the prior 24 months. An ineligible company is one whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. Examples can be found at accme.org.
Nature of Financial Relationships
Faculty participating in an ACR-sponsored activity must disclose to the planning committee and audience all financial or other relationships with ineligible companies including, but not limited to:
- Advisor or review panel member
- Officer or Board Member
- Grant/research support
- Speaker/honoraria includes speakers bureau, symposia, and expert witness
- Independent contractor
- Ownership interest
- Intellectual property/patents
- Stock options or bond holdings in a for-profit corporation or self-directed pension plan
- Other financial or material support
None: Has no relevant financial relationship(s) with ineligible companies to disclose.
The planning committee and faculty reported the following disclosures.
The following planning committee members have no relevant financial relationship(s) with ineligible companies to disclose.
- Charles Haberkern, MBA
- Rebecca Shepherd, MD, MBA
- Marcus Snow, MD
- Sarah Bayefsky, MD
- Adam Kilian, MD
- Bethany Marston, MD
- Benjamin Smith, PA-C
- Irene Tan, MD
- Melesia Tillman
- Saud Abaalkhail, MD
- Seth Berney, MD
- Anna Broder, MD, MSc
- Jim Oates, MD
- Debendra Pattanaik, MD
- Natasha Ruth, MD
- Sarah Baxter, MD, PhD
- Margaret Chang, MD, PhD
- Patrick Corrigan, DPT, PhD
- Ali Duarte, MD
- Ruth Fernandez Ruiz, MD, MSc
- Tate Johnson, MD
- Emily Smitherman, MD
- Louise Thoma, PhD, DPT
- Yu (Ray) Zuo, MD, MS
- Sean Fahey, MD
- Rebecca Manno, MD, MHS
- Ann Cameron Barr, MD
- Rashmi Dhital, MD
- Mohanad Elfishawi, MBBCh, MS
- Mario David Felix, MD
- Ibtissam Gad, MD
- Guy Katz, MD
- Karen Kruzer, MD
- Sara T. Patrizi, DO
- Jessica Perfetto, MD
- Didem Saygin, MD
- Austin Wheeler, MD
- Matthew Bunyard, MD
- Kevin Byrum, MD
- Sobia Hassan, RhMSUS, MRCP, MBBS
- Lisa Korn, PhD
- Aman Kugasia, MD
- Liana Fraenkel, MD, MPH
The following planning committee members have relevant financial relationship(s) with ineligible companies to disclose.
- Fotios Koumpouras, MD – AstraZeneca (Consultant/Speaker), GSK (Consultant/Speaker), Aurinia (Consultant), BMS (Consultant), Novartis (Consultant)
- Laura Sampson, PA-C – Novartis (Advisor Board), Eli Lilly (Advisory Board)
- Vaneet Sandhu, MD – GSK (Speaker), Aurinia (Speaker)
- Stacey Tarvin, MD – Pfizer (PI), UCB (PI), Roche (PI)
- Randy Cron, MD, PhD – Sobi (Consultant, CT Support), Pfizer (CT Adjudication Committee), Apollo Therapeutics (Consultant), AbbVie (CT Adjudication Committee), MedStudy (Board Review Lecturer), Lilly & Vindico Medical Education (Curbside Consultant/Speaker)
- Eyal Muscal, MD, MSc – Sobi (Consultant, Advisory Board)
- Shanthini Kasturi, MD, MS – GSK (Advisor)
- Hanna Kim, MD – Eli Lilly (Research Support)
- Maximilian Konig, MD – Argenx (Consultant), Revel (Consultant)
- Bella Mehta, MBBS, MS – Novartis (Educational Content Development)
- Naomi Patel, MD – FVC Health (Consultant), Alosa Health (Consultant)
- Kam Nola, MS, PharmD – Eli Lilly (Stock)
View ACR's ACCME disclosure practices